Business · Companies · 6 hrs ago
Argenx to buy Unnatural Products in deal worth up to $1.15 billion
Argenx said it will acquire Unnatural Products in a deal announced on Monday.
Unnatural Products is a macrocycle biotechnology company that started out in a garage.
The deal could be worth up to about $1.15 billion.
Argenx CEO Karen Massey and Unnatural Products CEO Cameron Pye were named in connection with the announcement.
The acquisition brings together two biotechnology companies.
The announcement did not specify when the acquisition would be completed or describe the next steps.
Argenx said it will buy macrocycle biotech Unnatural Products in a deal worth up to about $1.15 billion.
The company described Unnatural Products as a biotech that started out of a garage.
The announcement was reported on November 9, 2026.
The article identifies Karen Massey as Argenx’s CEO and Cameron Pye as Unnatural Products’ CEO.
- Who
- Argenx and Unnatural Products.
- What
- Argenx said it will buy Unnatural Products in a deal worth up to about $1.15 billion.
- When
- November 9, 2026.
- Where
- Not stated.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Deal value
- Up to about $1.15 billion
- Buyer
- Argenx
- Company being acquired
- Unnatural Products
- Announcement date
- November 9, 2026